BFR Training for ACL Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how a special device called AirBand might aid recovery from ACL (a knee ligament) surgery. The researchers aim to determine if restricting blood flow during rehab exercises can alter immune cell activities and gene expression, potentially speeding up recovery. Participants will use both inflated and uninflated versions of the AirBand to compare effects. The trial suits individuals who have undergone ACL surgery, are in generally good health, and can attend two study sessions at least one week apart. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could improve recovery methods for ACL surgery patients.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, you cannot participate if you are using anticoagulant medications or have been treated with another investigational drug within one month of the study start.
What is the safety track record for AirBand?
Research has shown that blood flow restriction (BFR) therapy, such as that used with AirBand, is generally easy to handle. Studies have found that BFR can help maintain muscle strength and aid recovery after surgeries like ACL reconstruction. Although long-term safety data on BFR is limited, current research suggests it is safe when used properly. Some individuals might experience mild discomfort during use, but serious side effects are rare. Overall, AirBand and similar devices are considered safe for short-term use in rehabilitation.12345
Why are researchers excited about this trial?
Researchers are excited about the BFR (Blood Flow Restriction) Training for ACL recovery because it offers a unique approach compared to traditional rehabilitation methods. Unlike standard exercises that rely on heavy weights to rebuild muscle strength after an ACL injury, BFR uses an inflatable device such as the AirBand to restrict blood flow, allowing muscles to grow stronger using lighter weights. This method can reduce stress on the healing joint, potentially speeding up recovery and reducing the risk of re-injury. Additionally, the AirBand's ability to be used both inflated and uninflated provides flexibility in treatment, making it adaptable for different stages of recovery.
What evidence suggests that AirBand BFR Training is effective for ACL recovery?
Research has shown that blood flow restriction (BFR) therapy, such as the AirBand, holds promise for ACL recovery. In this trial, participants will undergo both inflated and uninflated AirBand sessions. Studies indicate that BFR helps maintain muscle strength and size during rehabilitation without heavy weights, which is especially beneficial post-surgery. One review found that BFR can reduce muscle loss in the thigh after ACL surgery and may lead to better recovery outcomes than traditional exercises alone. Overall, evidence supports BFR as an effective method to aid recovery after ACL reconstruction.56789
Who Is on the Research Team?
Rachel Perry, PhD
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-60 who are in good health and currently rehabilitating from anterior cruciate ligament reconstruction. Participants must be willing to follow the study procedures and have no recent smoking history, febrile illness, vascular issues in legs, or serious medical conditions like diabetes or rheumatoid arthritis.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo two training sessions with blood flow restriction (BFR) and control interventions using AirBands
Follow-up
Participants are monitored for immunometabolic responses and gene expression changes after each training session
What Are the Treatments Tested in This Trial?
Interventions
- AirBand
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor